FDA Inspection
Cardinal Health, IncCardinal Health, Inc – FDA Inspection, Feb 21, 2026
Record Details
This FDA Inspection record concerns Cardinal Health, Inc, with an inspection on February 21, 2026, issued by the Dallas District Office, covering human drugs.
View Company Profile
ID · 0021303a-8b41-48f4-b287-2593fa23a601
Inspection Facts
- Inspection number
- 1304424
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 212.110(b)Record quality
- 21 CFR 212.60(e)Equipment
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Cardinal Health, Inc
3| Date | Classification | Office | Project area |
|---|---|---|---|
| May 26, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 18, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 17, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Cardinal Health, Inc
- FDA Inspection 977922 - 2016-05-26
- FDA Inspection 892549 - 2014-08-18
- FDA Inspection 799530 - 2012-09-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.